These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

209 related articles for article (PubMed ID: 28208810)

  • 41. XBP1 induces snail expression to promote epithelial- to-mesenchymal transition and invasion of breast cancer cells.
    Li H; Chen X; Gao Y; Wu J; Zeng F; Song F
    Cell Signal; 2015 Jan; 27(1):82-9. PubMed ID: 25280941
    [TBL] [Abstract][Full Text] [Related]  

  • 42. 53BP1 suppresses epithelial-mesenchymal transition by downregulating ZEB1 through microRNA-200b/429 in breast cancer.
    Kong X; Ding X; Li X; Gao S; Yang Q
    Cancer Sci; 2015 Aug; 106(8):982-9. PubMed ID: 26011542
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Inhibition of SHP2 leads to mesenchymal to epithelial transition in breast cancer cells.
    Zhou XD; Agazie YM
    Cell Death Differ; 2008 Jun; 15(6):988-96. PubMed ID: 18421299
    [TBL] [Abstract][Full Text] [Related]  

  • 44. 2-Hydroxycinnamaldehyde inhibits the epithelial-mesenchymal transition in breast cancer cells.
    Ismail IA; Kang HS; Lee HJ; Chang H; Yun J; Lee CW; Kim NH; Kim HS; Yook JI; Hong SH; Kwon BM
    Breast Cancer Res Treat; 2013 Feb; 137(3):697-708. PubMed ID: 23283523
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Association of Shp2 with phosphorylated IL-22R1 is required for interleukin-22-induced MAP kinase activation.
    Meng S; Gui Q; Xu Q; Lu K; Jiao X; Fan J; Ge B; Ke Y; Zhang S; Wu J; Wang C
    J Mol Cell Biol; 2010 Aug; 2(4):223-30. PubMed ID: 20671117
    [TBL] [Abstract][Full Text] [Related]  

  • 46. DYRK2 controls the epithelial-mesenchymal transition in breast cancer by degrading Snail.
    Mimoto R; Taira N; Takahashi H; Yamaguchi T; Okabe M; Uchida K; Miki Y; Yoshida K
    Cancer Lett; 2013 Oct; 339(2):214-25. PubMed ID: 23791882
    [TBL] [Abstract][Full Text] [Related]  

  • 47. SH2 domain-containing phosphatase-2 protein-tyrosine phosphatase promotes Fc epsilon RI-induced activation of Fyn and Erk pathways leading to TNF alpha release from bone marrow-derived mast cells.
    McPherson VA; Sharma N; Everingham S; Smith J; Zhu HH; Feng GS; Craig AW
    J Immunol; 2009 Oct; 183(8):4940-7. PubMed ID: 19786542
    [TBL] [Abstract][Full Text] [Related]  

  • 48. HCRP1 downregulation promotes hepatocellular carcinoma cell migration and invasion through the induction of EGFR activation and epithelial-mesenchymal transition.
    Xu J; Zhang X; Wang H; Ge S; Gao T; Song L; Wang X; Li H; Qin Y; Zhang Z
    Biomed Pharmacother; 2017 Apr; 88():421-429. PubMed ID: 28122307
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Sox5 induces epithelial to mesenchymal transition by transactivation of Twist1.
    Pei XH; Lv XQ; Li HX
    Biochem Biophys Res Commun; 2014 Mar; 446(1):322-7. PubMed ID: 24607904
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Negative regulation of gp130 signalling mediated through tyrosine-757 is not dependent on the recruitment of SHP2.
    Fairlie WD; De Souza D; Nicola NA; Baca M
    Biochem J; 2003 Jun; 372(Pt 2):495-502. PubMed ID: 12593670
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Aberrantly expressed Fra-1 by IL-6/STAT3 transactivation promotes colorectal cancer aggressiveness through epithelial-mesenchymal transition.
    Liu H; Ren G; Wang T; Chen Y; Gong C; Bai Y; Wang B; Qi H; Shen J; Zhu L; Qian C; Lai M; Shao J
    Carcinogenesis; 2015 Apr; 36(4):459-68. PubMed ID: 25750173
    [TBL] [Abstract][Full Text] [Related]  

  • 52. CRH suppressed TGFβ1-induced Epithelial-Mesenchymal Transition via induction of E-cadherin in breast cancer cells.
    Jin L; Chen J; Li L; Li C; Chen C; Li S
    Cell Signal; 2014 Apr; 26(4):757-65. PubMed ID: 24412750
    [TBL] [Abstract][Full Text] [Related]  

  • 53. The monoamine oxidase-A inhibitor clorgyline promotes a mesenchymal-to-epithelial transition in the MDA-MB-231 breast cancer cell line.
    Satram-Maharaj T; Nyarko JN; Kuski K; Fehr K; Pennington PR; Truitt L; Freywald A; Lukong KE; Anderson DH; Mousseau DD
    Cell Signal; 2014 Dec; 26(12):2621-32. PubMed ID: 25152370
    [TBL] [Abstract][Full Text] [Related]  

  • 54. SHP2 mediates the localized activation of Fyn downstream of the α6β4 integrin to promote carcinoma invasion.
    Yang X; Dutta U; Shaw LM
    Mol Cell Biol; 2010 Nov; 30(22):5306-17. PubMed ID: 20855525
    [TBL] [Abstract][Full Text] [Related]  

  • 55. SHP2 tyrosine phosphatase stimulates CEBPA gene expression to mediate cytokine-dependent granulopoiesis.
    Zhang L; Friedman AD
    Blood; 2011 Aug; 118(8):2266-74. PubMed ID: 21725048
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Glucocorticoid receptor-IRS-1 axis controls EMT and the metastasis of breast cancers.
    Shi W; Wang D; Yuan X; Liu Y; Guo X; Li J; Song J
    J Mol Cell Biol; 2019 Dec; 11(12):1042-1055. PubMed ID: 30726932
    [TBL] [Abstract][Full Text] [Related]  

  • 57. [The Biological Function of SHP2 in Human Disease].
    Li SM
    Mol Biol (Mosk); 2016; 50(1):27-33. PubMed ID: 27028808
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Deletion of the tyrosine phosphatase Shp2 in cervical cancer cells promotes reprogramming of glutamine metabolism.
    Gao X; Kang J; Li X; Chen C; Luo D
    FASEB J; 2023 Apr; 37(4):e22880. PubMed ID: 36943407
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Protein Tyrosine Phosphatase SHP2 Controls Interleukin-8 Expression in Breast Cancer Cells.
    Amante RJ; Auf der Maur P; Richina V; Sethi A; Iesmantavicius V; Bonenfant D; Aceto N; Bentires-Alj M
    J Mammary Gland Biol Neoplasia; 2022 Jun; 27(2):145-153. PubMed ID: 35739379
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Tyrosine phosphatase SHP2 regulates the expression of acyl-CoA synthetase ACSL4.
    Cooke M; Orlando U; Maloberti P; Podestá EJ; Cornejo Maciel F
    J Lipid Res; 2011 Nov; 52(11):1936-48. PubMed ID: 21903867
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.